IRMA-International.org: Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

Neurophytomedicine: A Critical Review of Traditional Herbal Anxiolytics

Neurophytomedicine: A Critical Review of Traditional Herbal Anxiolytics
View Sample PDF
Author(s): Sreya Kosanam (Dr. M.G.R. Educational and Research Institute, India), Revathi Boyina (QIS College of Pharmacy, India), A. M. T. Gurubasavaraj (YSS College of Pharmacy, India), K. M. D. Muzammil (YSS College of Pharmacy, India), R. Praveen Javali (Sri Raghavendra College of Pharmacy, Chitradurga, India), Adinarayana Andy (Weatherwax Family Pharmacies Inc., USA)and Aman Suresh Tharayil (Dr. M.G.R. Educational and Research Institute, India)
Copyright: 2026
Pages: 38
Source title: Pharmacology, Characterizations, Toxicity, and Herb-Drug Interactions of Herbs in Traditional Medicine
Source Author(s)/Editor(s): Olubunmi Atolani (University of Ilorin, Nigeria), Learnmore Kambizi (Cape Peninsula University of Technology, South Africa)and M.T. Bakare-Odunola (University of Ilorin, Nigeria)
DOI: 10.4018/979-8-3373-5876-5.ch003

Purchase

View Neurophytomedicine: A Critical Review of Traditional Herbal Anxiolytics on the publisher's website for pricing and purchasing information.

Abstract

This chapter examines the scientific and clinical foundations of traditional herbal anxiolytics within the emerging field of neurophytomedicine. It explores the global prevalence and neurobiology of anxiety disorders, limitations of conventional pharmacological treatments, and the therapeutic potential of botanicals with historical use in anxiety relief. Emphasis is placed on phytochemical classes such as flavonoids, terpenes, alkaloids, and saponins, and their mechanisms of action on GABAergic, serotonergic, and hypothalamic pituitary adrenal systems. Comparative clinical evidence, safety considerations, herb-drug interactions, and regulatory frameworks are critically reviewed. The chapter also addresses challenges in standardization, placebo effects in trials, and ethical sourcing of medicinal plants. Finally, it outlines future directions including pharmacogenomic personalization, AI-driven phytochemical discovery, and integration of validated botanicals into mainstream psychiatry.

Related Content

Abisola Aminat Afolabi, Emmanuel Henry Ezenabor, Godwin Ayebaitari Berena. © 2026. 34 pages.
Temidayo Daniel Adeniyi, Akinpelu Moronkeji, Godwin Olawoyin Adunmo, Gbadebo Maroof Oyeniyi, Emmanuel Tolulope Adegoke, Oluwadarasimi Osundara, Hanifat Abake Olaitan. © 2026. 46 pages.
Sreya Kosanam, Revathi Boyina, A. M. T. Gurubasavaraj, K. M. D. Muzammil, R. Praveen Javali, Adinarayana Andy, Aman Suresh Tharayil. © 2026. 38 pages.
Bui Thi Hao, Nguyen Thi Anh Hong, Nguyen Minh Khoi, Bui Thanh Tung. © 2026. 18 pages.
Taye Temitope Alawode. © 2026. 34 pages.
Damilare Rotimi, Victor Oluwadamilare Adeogun, Oluyomi Stephen Adeyemi. © 2026. 26 pages.
Chhan Kumar Kalita, Awadhesh Kumar. © 2026. 32 pages.
Body Bottom